Serum-mediated immune cellular responses to Brucella melitensis. I. Role of a macrophage-stimulating factor in promoting ingestion of Brucella by streptomycin-protected cells.
Injection of rabbits with living Brucella melitensis Rev I induced the appearance of a macrophage-stimulating-factor (MSF) in the sera of these animals. MSF was involved in ingestion of bacilli, hastening the formation of protected loci as measured by the addition of lethal amounts of dihydrostreptomycin. When sufficient time had been allowed for effective ingestion, streptomycin had little effect. This in turn allowed for multiplication of bacilli intracellularly in the presence of 5 to 250 mug of drug per ml. MSF mediated more effective ingestion by both immune and normal macrophages. Under such conditions, there was little, if any, intracellular growth restriction by macrophages from immune animals. The activity appeared within the first 5 days after injection with 10(9) organisms and was present for several months. Three weeks after injection, the activity of serum was partially heat-labile. All activity was removed by absorption with heat-killed or living Rev I cells, suggesting that a specific globulin is concerned.
D001769:Blood; D002002:Brucella / Q000276:immunology*; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology*; D007109:Immunity; D007114:Immunization; D008264:Macrophages / Q000502:physiology*; D010587:Phagocytosis
D004096:Dihydrostreptomycin Sulfate